Form4insider filings, from the source

SEC Form 3 · accession 0001388410-18-000069

PARALLAX HEALTH SCIENCES, INC. · PRLX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nathaniel T Bradley
Director · Other
Period of report
Jun 4, 2018
Accepted (ET)
Oct 12, 2018 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKF1holding———1,000,000IBy Bradley Bros LLC
COMMON STOCKF2holding———1,228,346IBy Bradley Bros LLC
COMMON STOCKF3holding———3,000,000IBy Bradley Bros LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
STOCK OPTIONSF1$0.10holding———Aug 31, 2017Aug 31, 2020COMMON STOCK200,000—D
STOCK OPTIONSF1$0.15holding———Aug 31, 2017Aug 31, 2020COMMON STOCK125,000—D
STOCK OPTIONSF1$0.25holding———Aug 31, 2017Aug 31, 2020COMMON STOCK100,000—D
STOCK OPTIONSF3$0.25holding———Aug 1, 2017Aug 1, 2022COMMON STOCK250,000—D
STOCK OPTIONSF3$0.25holding———Aug 1, 2018Aug 1, 2022COMMON STOCK250,000—D
STOCK OPTIONSF3$0.25holding———Aug 1, 2019Aug 1, 2022COMMON STOCK250,000—D
STOCK OPTIONSF3$0.25holding———Aug 1, 2020Aug 1, 2022COMMON STOCK250,000—D

Explanation of responses